Toshifumi Hibi

18PUBLICATIONS
58CO-AUTHORS
Immunogenetics (incl. genetic immunology)Molecular targetsPredictive and prognostic markersPacific Peoples cultural determinants of healthAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Sep 08, 2026
Association Between Bowel Urgency and Intestinal Ultrasound Parameters in Ulcerative Colitis: Insights Into Transmural Inflammation and Symptom Pathophysiology.

|Feb 24, 2026
Safety and efficacy of long-term filgotinib treatment in Japanese patients with ulcerative colitis: an interim subgroup analysis of the SELECTION long-term extension study.

Katsuyoshi Matsuoka, Erina Hata, Toshihiko Kaise

|May 15, 2025
Real-World Effectiveness and Safety of Vedolizumab in Patients ≥ 70 Versus < 70 Years With Ulcerative Colitis: Multicenter Retrospective Study.

Tadakazu Hisamatsu, Taku Kobayashi, Satoshi Motoya

|Feb 27, 2025
Patient and Health Care Professional Perspectives on the Burden and Daily Life Impact of Ulcerative Colitis and Crohn's Disease: Results from the Japanese CONFIDE Study.

Toshifumi Hibi, Taku Kobayashi, Masaru Tanaka

|Dec 06, 2024
Leucine-Rich Alpha-2 Glycoprotein Is Associated With Transmural Inflammation Assessed by Intestinal Ultrasound in Patients With Crohn's Disease.

Moeko Komatsu, Shintaro Sagami, Aya Hojo

|Oct 25, 2024
Distinct trajectories of symptomatic response in ulcerative colitis during filgotinib therapy: A post hoc analysis from the SELECTION study.

Stefan Schreiber, Brian G Feagan, Edouard Louis

Pageof 3

Frequent Collaborators

8 joint publications

Taku Kobayashi

5 joint publications

Shintaro Sagami

5 joint publications

Katsuyoshi Matsuoka

5 joint publications

Tadakazu Hisamatsu